Related Experiment Video

Updated: Dec 9, 2025

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

7.9K

MiR-422a in gastric cancer cells directly targets CDC40 and modulates cell proliferation

Fanglai Zhu1, Hao Li1, Fei Ding1

  • 1Department of Gastroenterology, The First People's Hospital of Anqing Anqing, Anhui, China.

American Journal of Translational Research
|September 11, 2020
PubMed

Insights

This study reveals that miR-422a acts as a tumor suppressor in gastric cancer by downregulating cell division cycle 40 (CDC40), inhibiting cancer cell proliferation.

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • MicroRNAs regulate gene expression and are implicated in human cancers.
  • Their specific roles in gastric cancer pathogenesis require further elucidation.

Purpose of the Study:

  • To investigate the role of miR-422a in gastric cancer.
  • To identify the molecular targets and mechanisms of miR-422a in this disease.

Main Methods:

  • Quantification of miR-422a and CDC40 expression in gastric cancer tissues and cells.
  • Dual-luciferase reporter assays to confirm direct targeting of CDC40 by miR-422a.
  • Assessment of miR-422a restoration effects on gastric cancer cell proliferation.

Main Results:

  • Gastric cancer tissues and cells exhibited decreased miR-422a expression and increased cell division cycle 40 (CDC40) expression.
  • miR-422a was confirmed to directly target and downregulate CDC40.
  • Restoring miR-422a expression significantly inhibited gastric cancer cell proliferation.

Conclusions:

  • miR-422a functions as a tumor suppressor in gastric cancer by targeting CDC40.
  • Downregulation of miR-422a and subsequent upregulation of CDC40 contribute to gastric cancer development and progression.
  • miR-422a represents a potential therapeutic target for gastric cancer.
Keywords:
CDC40gastric cancermiR-422aproliferation

More Related Videos

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

2.0K
An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

8.7K

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.5K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.5K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.4K